*AKZONOBEL REJECTED OFFER FROM NIPPON PAINT, SHERWIN-WILLIAMS *AKZONOBEL SAYS CASH OFFER REJECTED ON MAY 1, ’26 *AKZONOBEL SAYS CASH OFFER WAS FOR €73.00 IN CASH/SHR *AKZONOBEL BOARD CONTINUES TO RECOMMEND AXALTA MERGER

DOJ Appears Set to Approve Paramount’s Warner Bros Bid: Semafor

H.B. Fuller Issues Statement Regarding Value Creation Strategy

BILL Announces Executive Leadership Appointments and Organizational Updates to Support Next Phase of Growth

Lululemon Nears Deal to End Proxy War With Chip Wilson: Rtrs

Genco Shipping & Trading Limited Sets the Record Straight on Numerous Falsehoods in Diana’s Investor Presentation #PlsStop

REVERSE FLEX: Warner Bros. Discovery ~$12.5-13.75b, EU1-2b TLBs (financing work marching along)

*BLACKSTONE INJECTING UP TO $1.3 BILLION IN APOGEE FOR SKIN DRUG

FTSE Russell adopted a rule change that will speed the addition of newly listed large-cap companies to its main indexes, weeks ahead of SpaceX’s expected record-breaking IPO #Pump&Dump

*Nano Dimension Announces Sale of MarkForged to Stratasys

NEUP: a microcap name on my radar because Lynx1 (16% hds) bid $4.75 in late ’25:

• Neuphoria Therapeutics Inc.: 8-K: ” … Based on past program contributions, Neuphoria believes it is eligible to receive approximately 4.65% of future milestone payments, if any, from CTXT, of which the total value to all 17 parties (see below) combined is estimated to be USD$460M …”